Literature DB >> 22068236

Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40.

Xiaochang Xue1, Ting Feng, Suxia Yao, Kyle J Wolf, Chang-Gong Liu, Xiuping Liu, Charles O Elson, Yingzi Cong.   

Abstract

Commensal flora plays important roles in the regulation of the gene expression involved in many intestinal functions and the maintenance of immune homeostasis, as well as in the pathogenesis of inflammatory bowel diseases. The microRNAs (miRNAs), a class of small, noncoding RNAs, act as key regulators in many biological processes. The miRNAs are highly conserved among species and appear to play important roles in both innate and adaptive immunity, as they can control the differentiation of various immune cells, as well as their functions. However, it is still largely unknown how microbiota regulates miRNA expression, thereby contributing to intestinal homeostasis and pathogenesis of inflammatory bowel disease. In our current study, we found that microbiota negatively regulated intestinal miR-10a expression, because the intestines, as well as intestinal epithelial cells and dendritic cells of specific pathogen-free mice, expressed much lower levels of miR-10a compared with those in germ-free mice. Commensal bacteria downregulated dendritic cell miR-10a expression via TLR-TLR ligand interactions through a MyD88-dependent pathway. We identified IL-12/IL-23p40, a key molecule for innate immune responses to commensal bacteria, as a target of miR-10a. The ectopic expression of the miR-10a precursor inhibited, whereas the miR-10a inhibitor promoted, the expression of IL-12/IL-23p40 in dendritic cells. Mice with colitis expressing higher levels of IL-12/IL-23p40 exhibited lower levels of intestinal miR-10a compared with control mice. Collectively, our data demonstrated that microbiota negatively regulates host miR-10a expression, which may contribute to the maintenance of intestinal homeostasis by targeting IL-12/IL-23p40 expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22068236      PMCID: PMC3226774          DOI: 10.4049/jimmunol.1100535

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

2.  MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2.

Authors:  Jin Hou; Pin Wang; Li Lin; Xingguang Liu; Feng Ma; Huazhang An; Zhugang Wang; Xuetao Cao
Journal:  J Immunol       Date:  2009-07-13       Impact factor: 5.422

3.  Effect of IL-12 and antibodies to IL-12 on established granulomatous colitis in mice.

Authors:  M F Neurath; I Fuss; B Kelsall; K H Meyer zum Büschenfelde; W Strober
Journal:  Ann N Y Acad Sci       Date:  1996-10-31       Impact factor: 5.691

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

5.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 6.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

7.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

8.  Angiogenins: a new class of microbicidal proteins involved in innate immunity.

Authors:  Lora V Hooper; Thaddeus S Stappenbeck; Chieu V Hong; Jeffrey I Gordon
Journal:  Nat Immunol       Date:  2003-01-27       Impact factor: 25.606

9.  A microbial symbiosis factor prevents intestinal inflammatory disease.

Authors:  Sarkis K Mazmanian; June L Round; Dennis L Kasper
Journal:  Nature       Date:  2008-05-29       Impact factor: 49.962

10.  Interleukin-23 drives intestinal inflammation through direct activity on T cells.

Authors:  Philip P Ahern; Chris Schiering; Sofia Buonocore; Mandy J McGeachy; Dan J Cua; Kevin J Maloy; Fiona Powrie
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

View more
  68 in total

Review 1.  Functional regulation of monocyte-derived dendritic cells by microRNAs.

Authors:  Yifan Zhan; Li Wu
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

Review 2.  Gut microbiota modulate the immune effect against hepatitis B virus infection.

Authors:  D Xu; Y Huang; J Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-14       Impact factor: 3.267

3.  MicroRNA-193a-3p Reduces Intestinal Inflammation in Response to Microbiota via Down-regulation of Colonic PepT1.

Authors:  Xin Dai; Xi Chen; Qun Chen; Lei Shi; Hongwei Liang; Zhen Zhou; Qian Liu; Wenjing Pang; Dongxia Hou; Cheng Wang; Ke Zen; Yaozong Yuan; Chen-Yu Zhang; Lu Xia
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

Review 4.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

5.  Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs.

Authors:  Makon-Sébastien Njock; Henry S Cheng; Lan T Dang; Maliheh Nazari-Jahantigh; Andrew C Lau; Emilie Boudreau; Mark Roufaiel; Myron I Cybulsky; Andreas Schober; Jason E Fish
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

Review 6.  Role of MiRNAs in Inflammatory Bowel Disease.

Authors:  Bo Cao; Xin Zhou; Jiaojiao Ma; Wei Zhou; Wanli Yang; Daiming Fan; Liu Hong
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

Review 7.  Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.

Authors:  Alieh Gholaminejad; Hossein Abdul Tehrani; Mohammad Gholami Fesharaki
Journal:  J Nephrol       Date:  2018-07-17       Impact factor: 3.902

Review 8.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

9.  Delayed IL-12 production by macrophages during Toxoplasma gondii infection is regulated by miR-187.

Authors:  Heng Jiang; Tao Zhai; Yanhui Yu; Xin Li; Pengtao Gong; Xichen Zhang; Guojiang Li; Jianhua Li
Journal:  Parasitol Res       Date:  2020-02-17       Impact factor: 2.289

10.  MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway.

Authors:  Ruoxi Hu; Wenchi Pan; Alexey V Fedulov; William Jester; Matthew R Jones; Scott T Weiss; Reynold A Panettieri; Kelan Tantisira; Quan Lu
Journal:  FASEB J       Date:  2014-02-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.